Clinical Trial Update: Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: NHS Blood and Transplant | Conditions: Sickle Cell Disease | Phase 3 | Status: TERMINATED